|
|
|
Volumn 20, Issue 4, 2001, Pages 177-180
|
|
The withdrawal of Baycol (cerivastatin)
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTILIPEMIC AGENT;
ATORVASTATIN;
AZITHROMYCIN;
BARBITURIC ACID DERIVATIVE;
BENZODIAZEPINE DERIVATIVE;
BEZAFIBRATE;
CERIVASTATIN;
CIPROFIBRATE;
CLARITHROMYCIN;
CLOFIBRATE;
COLCHICINE;
CREATINE KINASE;
CYCLOSPORIN;
DIAMORPHINE;
ENFLURANE;
ERYTHROMYCIN;
FENOFIBRATE;
FIBRIC ACID DERIVATIVE;
FLUINDOSTATIN;
GEMFIBROZIL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
MACROLIDE;
MEVINOLIN;
MIBEFRADIL;
NONSTEROID ANTIINFLAMMATORY AGENT;
PHENOTHIAZINE DERIVATIVE;
PRAVASTATIN;
SIMVASTATIN;
THEOPHYLLINE;
UNINDEXED DRUG;
DRUG BIOAVAILABILITY;
DRUG INHIBITION;
DRUG MEGADOSE;
DRUG METABOLISM;
DRUG WITHDRAWAL;
EDITORIAL;
GOUT;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERLIPIDEMIA;
HYPERTHYROIDISM;
INCIDENCE;
KIDNEY FAILURE;
MUSCLE INJURY;
MYALGIA;
MYOGLOBINURIA;
MYOPATHY;
MYOSITIS;
RHABDOMYOLYSIS;
RISK ASSESSMENT;
SYSTEMIC LUPUS ERYTHEMATOSUS;
TOXICITY TESTING;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
ANTILIPEMIC AGENTS;
DRUG AND NARCOTIC CONTROL;
DRUG INDUSTRY;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
PYRIDINES;
RHABDOMYOLYSIS;
|
|
EID: 0035200292
PISSN: 0964198X
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (6)
|
|
References (12)
|
